Literature DB >> 19487220

Overview of pathogenesis of systemic sclerosis.

D J Abraham1, T Krieg, J Distler, O Distler.   

Abstract

The aetiology of SSc is subject to ongoing research, as the precise events that underlie the development of this disease remain unclear. The pathogenesis is known to involve endothelium, epithelium, fibroblasts, innate and adaptive immune systems and their component immunological mediators. Endothelial cell damage may be the initiating factor, but the precise triggering event(s) remain elusive. Angiogenesis also appears to be dysregulated. Vasculopathy shows similarities in different organs (e.g. pulmonary arterial hypertension, renal disease, digital tip ulcers). Endothelin-1 is a potent mediator of vasculopathy, and hence represents a highly relevant target for intervention of vascular features in SSc.

Entities:  

Mesh:

Year:  2009        PMID: 19487220     DOI: 10.1093/rheumatology/ken481

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  69 in total

1.  Heritability of vasculopathy, autoimmune disease, and fibrosis in systemic sclerosis: a population-based study.

Authors:  Tracy Frech; Dinesh Khanna; Boaz Markewitz; Geraldine Mineau; Richard Pimentel; Allen Sawitzke
Journal:  Arthritis Rheum       Date:  2010-07

2.  Serum resistin levels: a possible correlation with pulmonary vascular involvement in patients with systemic sclerosis.

Authors:  Yuri Masui; Yoshihide Asano; Kaname Akamata; Naohiko Aozasa; Shinji Noda; Takashi Taniguchi; Takehiro Takahashi; Yohei Ichimura; Tetsuo Toyama; Hayakazu Sumida; Yoshihiro Kuwano; Koichi Yanaba; Yayoi Tada; Makoto Sugaya; Shinichi Sato; Takafumi Kadono
Journal:  Rheumatol Int       Date:  2013-10-19       Impact factor: 2.631

Review 3.  Vasculopathy in scleroderma.

Authors:  Yoshihide Asano; Shinichi Sato
Journal:  Semin Immunopathol       Date:  2015-07-08       Impact factor: 9.623

4.  Tc-99m diethylenetriamine pentaacetic acid (DTPA) renal function reserve estimation: is it a reliable predictive tool for assessment of preclinical renal involvement in scleroderma patients?

Authors:  Amr Amin; S El-Sayed; N Taher; M Sedki; H Nasr
Journal:  Clin Rheumatol       Date:  2012-02-24       Impact factor: 2.980

5.  Pulmonary Arterial Hypertension-A Deadly Complication of Systemic Sclerosis.

Authors:  Edward A Pankey; Matthew Epps; Bobby D Nossaman; Albert L Hyman; Philip J Kadowitz
Journal:  J Clin Rheumatol Musculoskelet Med       Date:  2010-12-01

Review 6.  Role of MRI in diagnosis and management of idiopathic inflammatory myopathies.

Authors:  Britta Maurer; Ulrich A Walker
Journal:  Curr Rheumatol Rep       Date:  2015-11       Impact factor: 4.592

Review 7.  Progranulin: A key player in autoimmune diseases.

Authors:  Jinlong Jian; Guangfei Li; Aubryanna Hettinghouse; Chuanju Liu
Journal:  Cytokine       Date:  2016-08-12       Impact factor: 3.861

8.  Registry evaluation of digital ulcers in systemic sclerosis.

Authors:  Felice Galluccio; Marco Matucci-Cerinic
Journal:  Int J Rheumatol       Date:  2010-08-25

9.  Renal manifestations in scleroderma: evidence for subclinical renal disease as a marker of vasculopathy.

Authors:  Victoria K Shanmugam; Virginia D Steen
Journal:  Int J Rheumatol       Date:  2010-08-17

10.  Serum protein profiling of systemic lupus erythematosus and systemic sclerosis using recombinant antibody microarrays.

Authors:  Anders Carlsson; Dirk M Wuttge; Johan Ingvarsson; Anders A Bengtsson; Gunnar Sturfelt; Carl A K Borrebaeck; Christer Wingren
Journal:  Mol Cell Proteomics       Date:  2011-02-24       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.